| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $500,001 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Angel Matthew | CEO and President | 1 | $500,001 | 0 | $0 | $500,001 |
Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, …
Over the last 12 months, insiders at Tempest Therapeutics, Inc. have bought $500,001 and sold $0 worth of Tempest Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Tempest Therapeutics, Inc. have bought $1.87M and sold $967,033 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Angel Matthew (CEO and President) — $500,001.
The last purchase of 231,482 shares for transaction amount of $500,001 was made by Angel Matthew (CEO and President) on 2026‑03‑24.
| 2026-03-24 | Angel Matthew | CEO and President | 231,482 6.4337% | $2.16 | $500,001 | -38.29% | ||
| 2024-08-12 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 387,999 2.043% | $1.10 | $426,993 | -11.90% | |
| 2024-08-08 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 400,000 1.814% | $1.35 | $540,040 | -36.77% | |
| 2024-07-03 | Brady Stephen R | President and CEO | 35,000 0.1539% | $2.11 | $73,850 | -57.27% | ||
| 2024-07-02 | Whiting Samuel | Chief Medical Officer | 4,672 0.0207% | $2.13 | $9,951 | -57.31% | ||
| 2024-06-28 | Trojanowski Justin | Corporate Controller | 7,500 0.0338% | $2.16 | $16,200 | -58.48% | ||
| 2022-04-29 | Woiwode Thomas | 2.12M 11.9674% | $2.36 | $5M | -44.60% | |||
| 2022-01-07 | Dubensky Thomas W. | President | 2,000 0.0288% | $4.78 | $9,560 | -47.68% | ||
| 2022-01-06 | Whiting Samuel | Chief Medical Officer | 1,700 0.0243% | $4.80 | $8,168 | -48.40% | ||
| 2016-06-01 | Dipp Michelle | Chief Executive Officer | 425,000 1.3568% | $7.00 | $2.98M | -53.63% | ||
| 2016-06-01 | ALDRICH RICHARD | director | 425,000 1.3568% | $7.00 | $2.98M | -53.63% | ||
| 2016-05-18 | Dipp Michelle | Chief Executive Officer | 20,000 0.0671% | $7.86 | $157,200 | -53.14% | ||
| 2016-05-18 | ALDRICH RICHARD | director | 20,000 0.0671% | $7.86 | $157,200 | -53.14% | ||
| 2016-05-17 | Dipp Michelle | Chief Executive Officer | 20,000 0.0677% | $7.56 | $151,200 | -50.67% | ||
| 2016-05-17 | ALDRICH RICHARD | director | 20,000 0.0677% | $7.56 | $151,200 | -50.67% | ||
| 2016-05-16 | Dipp Michelle | Chief Executive Officer | 20,000 0.0668% | $7.69 | $153,800 | -51.69% | ||
| 2016-05-13 | Dipp Michelle | Chief Executive Officer | 16,295 0.055% | $7.06 | $115,043 | -46.48% | ||
| 2016-05-13 | ALDRICH RICHARD | director | 16,295 0.055% | $7.06 | $115,043 | -46.48% | ||
| 2016-05-12 | Dipp Michelle | Chief Executive Officer | 19,800 0.0679% | $6.84 | $135,352 | -43.52% | ||
| 2016-05-12 | ALDRICH RICHARD | director | 19,800 0.0679% | $6.84 | $135,352 | -43.52% |
| Angel Matthew | CEO and President | 231482 1.1577% | $108,472.47 | 1 | 0 | |
| Westphal Christoph H | 3820571 19.1073% | $1.79M | 2 | 0 | ||
| Longwood Fund, L.P. | 10 percent owner | 3820571 19.1073% | $1.79M | 2 | 0 | |
| Woiwode Thomas | 2118644 10.5957% | $992,796.58 | 1 | 0 | <0.0001% | |
| ALDRICH RICHARD | director | 962056 4.8114% | $450,819.44 | 29 | 0 | |
| Dipp Michelle | Chief Executive Officer | 962056 4.8114% | $450,819.44 | 29 | 0 | |
| Malley Thomas | director | 122200 0.6111% | $57,262.92 | 3 | 0 | |
| Dubensky Thomas W. | President | 113343 0.5668% | $53,112.53 | 1 | 0 | <0.0001% |
| Brady Stephen R | President and CEO | 46376 0.2319% | $21,731.79 | 1 | 0 | <0.0001% |
| Trojanowski Justin | Corporate Controller | 22168 0.1109% | $10,387.92 | 1 | 0 | <0.0001% |
| KOZIN MARC D | director | 20553 0.1028% | $9,631.14 | 3 | 0 | |
| Stock Harald F. | director | 13022 0.0651% | $6,102.11 | 10 | 0 | |
| CAPELLO JEFFREY D | director | 11111 0.0556% | $5,206.61 | 1 | 0 | |
| Whiting Samuel | Chief Medical Officer | 9573 0.0479% | $4,485.91 | 2 | 0 | <0.0001% |
| FISHER MARY | director | 6415 0.0321% | $3,006.07 | 1 | 0 | |
| Young Jeffrey E | Chief Financial Officer | 3750 0.0188% | $1,757.25 | 2 | 0 | |
| CHAPMAN PAUL W.D. | Chief Operating Officer | 3100 0.0155% | $1,452.66 | 1 | 0 | |
| Harding David | Chief Commercial Officer | 2290 0.0115% | $1,073.09 | 1 | 0 | |
| BLECK CHRISTOPHER A | Chief Commercial Officer | 2000 0.01% | $937.20 | 1 | 0 | |
| TZIANABOS ARTHUR | President and CSO | 400 0.002% | $187.44 | 3 | 0 | |
| McNeely Theresa | EVP, Chief Comm. Officer | 400 0.002% | $187.44 | 2 | 0 |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$76,600 | 22 | -38.58% | $10.49M | |
$555,628 | 21 | 43.52% | $12.04M | |
$365,792 | 12 | -15.77% | $12.38M |
| Increased Positions | 9 | +45% | 215,522 | +36.79% |
| Decreased Positions | 6 | -30% | 13,802 | -2.36% |
| New Positions | 6 | New | 205,661 | New |
| Sold Out Positions | 2 | Sold Out | 5,328 | Sold Out |
| Total Postitions | 23 | +15% | 787,544 | +34.43% |
| Versant Venture Management, Llc | $796.00 | 5.4% | 269,772 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $480.00 | 3.25% | 162,560 | +27,952 | +20.77% | 2025-09-30 |
| Geode Capital Management, Llc | $121.00 | 0.82% | 41,024 | +6,288 | +18.1% | 2025-09-30 |
| Blackrock, Inc. | $115.00 | 0.78% | 39,068 | 0 | 0% | 2025-09-30 |
| Fmr Llc | $98.00 | 0.67% | 33,226 | +<1 | +<0.01% | 2025-09-30 |
| Drw Securities, Llc | $56.00 | 0.38% | 18,828 | +18,828 | New | 2025-09-30 |
| Ubs Group Ag | $34.00 | 0.23% | 11,389 | +166 | +1.48% | 2025-09-30 |
| Belvedere Trading Llc | $16.00 | 0.11% | 5,325 | +5,325 | New | 2025-09-30 |
| Morgan Stanley | $6.00 | 0.04% | 2,108 | +<1 | +0.05% | 2025-09-30 |
| Osaic Holdings, Inc. | $5.00 | 0.03% | 1,655 | -179 | -9.76% | 2025-09-30 |